These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


521 related items for PubMed ID: 4974339

  • 1. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R.
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic fibrinolysis].
    Straub PW.
    Schweiz Med Wochenschr; 1973 May 19; 103(20):753-7. PubMed ID: 4702993
    [No Abstract] [Full Text] [Related]

  • 3. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M.
    Clin Ter; 1975 Jun 15; 73(5):403-22. PubMed ID: 1139864
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current data on diagnosis and treatment of thromboembolic states].
    Zosin P, Roth L.
    Med Interna (Bucur); 1972 Aug 15; 24(8):947-58. PubMed ID: 5080893
    [No Abstract] [Full Text] [Related]

  • 6. [Use of antithrombotic drugs in internal medicine].
    Vogel G, Huyke R.
    Z Gesamte Inn Med; 1979 Jan 01; 34(1):28-34. PubMed ID: 373276
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R.
    Z Arztl Fortbild (Jena); 1984 Jan 01; 78(5):167-71. PubMed ID: 6202068
    [No Abstract] [Full Text] [Related]

  • 8. Perspectives: fibrinolysis and thrombolysis.
    Sherry S.
    Thromb Diath Haemorrh Suppl; 1966 Jan 01; 20():1-12. PubMed ID: 5973051
    [No Abstract] [Full Text] [Related]

  • 9. Current developments in thrombolytic therapy.
    Sherry S.
    Thromb Diath Haemorrh Suppl; 1973 Jan 01; 56():201-10. PubMed ID: 4617330
    [No Abstract] [Full Text] [Related]

  • 10. [When is fibrinolytic therapy indicated?].
    Woitinas F.
    Med Klin; 1980 Feb 01; 75(3):98-107. PubMed ID: 6990218
    [No Abstract] [Full Text] [Related]

  • 11. Fibrinolytic guidelines in diabetes.
    Sharma GV, Mukerjee DK, Sasahara AA.
    Geriatrics; 1982 Apr 01; 37(4):38-42, 46. PubMed ID: 7060947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolytic therapy.
    Gallus AS.
    Compr Ther; 1976 Apr 01; 2(4):67-73. PubMed ID: 131019
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Current state and success of thrombolytic therapy].
    Deutsch E, Denk H, Fischer M.
    Wien Med Wochenschr; 1969 Feb 01; 119(5):85-9. PubMed ID: 4891686
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
    Wojczuk J.
    Wiad Lek; 1974 May 15; 27(10):877-82. PubMed ID: 4134634
    [No Abstract] [Full Text] [Related]

  • 18. [Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction].
    Schubert W.
    Z Gesamte Inn Med; 1972 Apr 01; 27(7):307-11. PubMed ID: 4625900
    [No Abstract] [Full Text] [Related]

  • 19. [Pharmacotherapy of venous disease].
    Marx R.
    Internist (Berl); 1967 Nov 01; 8(11):405-12. PubMed ID: 4174736
    [No Abstract] [Full Text] [Related]

  • 20. [Recent developments in the field of fibrinolytics and anticoagulants].
    Lechner K, Korninger C, Pabinger-Fasching I.
    Internist (Berl); 1984 Feb 01; 25(2):82-7. PubMed ID: 6368457
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.